Twitter Facebook LinkedIn
Center for Global Research Data

PATIENT REPORTED OUTCOME (PRO) AS A PROGNOSTIC MARKER IN PATIENTS TREATED WITH TARGETED THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA (PRO²-HCC)

Lead Investigator: Julien Edeline, Centre Eugene Marquis
Title of Proposal Research: PATIENT REPORTED OUTCOME (PRO) AS A PROGNOSTIC MARKER IN PATIENTS TREATED WITH TARGETED THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA (PRO²-HCC)
Vivli Data Request:7062
Funding Source: None
Potential Conflicts of Interest: Consultant for BMS, not related to the subject of the current research

Summary of the Proposed Research:

Quality of life could be a marker of the aggressiveness of a disease. We will study whether patient-rated quality of life could replace the evaluation of the general health status performed by the physician as a way to evaluate the prognosis of hepatocellular carcinoma.

Requested Studies:

First Line Hepato Cellular Carcinoma (HCC) (BRISK FL)
Data Contributor: Bristol Myers Squibb
Study ID: NCT00858871
Sponsor ID: NCT00858871